Navigation Links
Array BioPharma Provides Clinical Update On Filanesib (ARRY-520) For Multiple Myeloma At The 2013 American Society of Hematology Meeting
Date:12/9/2013

BOULDER, Colo., Dec. 9, 2013 /PRNewswire/ -- Array BioPharma Inc. (NASDAQ: ARRY) announced positive data for newly named filanesib (ARRY-520) as a single agent and in combination with proteasome inhibitors (PI) in patients with multiple myeloma (MM) at the 2013 Annual Meeting of the American Society of Hematology.

(Logo:  http://photos.prnewswire.com/prnh/20121029/LA02195LOGO)

Filanesib is a highly selective, targeted KSP inhibitor with a mechanism of action distinct from currently available drugs to treat MM such as immunomodulatory drugs (IMiD) and PIs.  Across multiple studies, filanesib has demonstrated activity in heavily pre-treated MM patients, with a consistent safety profile including no drug-induced peripheral neuropathy and limited non‑hematologic toxicity.  Adverse events are generally limited to transient, non-cumulative and predominantly asymptomatic hematologic effects. 

"Filanesib has shown clinical activity in relapsed/refractory multiple myeloma patients, both as a single agent, and in separate combination trials with Kyprolis and Velcade," said Jatin J. Shah, M.D., Assistant Professor, Lymphoma/Myeloma, Division of Cancer Medicine, The University of Texas, MD Anderson Cancer Center.  "These results support advancing filanesib into pivotal trials to confirm the promising activity we've seen to date."

"Multiple myeloma remains an incurable disease, with a significant unmet medical need in patients who are relapsed/refractory to IMiDs and proteasome inhibitors," said Michael Needle, M.D., Chief Medical Officer, Array BioPharma.  "Filanesib is a first-in class drug in myeloma that is well tolerated and has shown very encouraging clinical activity in hea
'/>"/>

SOURCE Array BioPharma
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Array BioPharma Announces Management Team Change
2. Array BioPharma To Present At The Jefferies 2013 Global Healthcare And Piper Jaffray 25th Annual Healthcare Conferences
3. Array BioPharma To Present Clinical Data At The 2013 ASH Annual Meeting On ARRY-520 For Multiple Myeloma And ARRY-614 For Myelodysplastic Syndromes
4. ARRAYit Corporation Receives Purchase Order from ChemBio
5. Array BioPharma Reports Financial Results For The First Quarter Of Fiscal 2014 And Announces ARRY-520 Development Strategy
6. Array BioPharma To Report Financial Results For The First Quarter Of Fiscal 2014 On October 31, 2013
7. Arrayit Corporation Announces New Corporate Headquarters in Sunnyvale California
8. ARRAYit Corporation Receives $104,000 Purchase Order from the University of California
9. ARRAYit Corporation Ships Proprietary Life Sciences Products to Google Inc.
10. ARRAYit Corporation Ships Proprietary Life Sciences Products to Illumina Inc.
11. Gentris Corporation Launches Next Generation Human Transcriptome Array
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/3/2015)... July 3, 2015 Redwood Pharma ... Technologies Co., Ltd., operating in both the US and ... proprietary IntelliGel ® supramolecular hydrogel technology in its ... other ophthalmic therapies. The Broda technology offers many unique ... a free-forming liquid and with low concentrations of polymer ...
(Date:7/2/2015)... , July 2, 2015 /PRNewswire/ - ESSA Pharma Inc. ... common shares have been approved for listing and trading on ... ESSA will begin trading on NASDAQ on July 9, ... Venture Exchange under the symbol "EPI". As a ... NASDAQ, each of the Company,s outstanding special warrants issued on ...
(Date:7/2/2015)... NYACK, N.Y. , July 2, 2015  Before you ... plan ahead so you can stay safe and healthy. Take ... plants #summersafety. Infographic http://nyackhospital.org/summersafety Protect Your ... rays from the sun can increase your risk of skin ... the shade as much as possible, especially during midday hours. ...
Breaking Medicine Technology:Redwood Pharma Licenses Novel Hydrogel Drug Delivery Technology From Broda Technologies 2ESSA Pharma Inc. to Commence Trading on the NASDAQ Capital Market 2ESSA Pharma Inc. to Commence Trading on the NASDAQ Capital Market 3ESSA Pharma Inc. to Commence Trading on the NASDAQ Capital Market 4First Aid Summer Survival Tips from Nyack Hospital 2First Aid Summer Survival Tips from Nyack Hospital 3
(Date:7/3/2015)... ... ... Renowned rhinoplasty surgeon and Symposium Chairman, Dr. Rod J. Rohrich , ... held from March 4th - 6th, the 2016 (a previous announcement had stated the ... to take participants from the basic training and fundamentals of nasal surgery through the ...
(Date:7/3/2015)... ... July 03, 2015 , ... B. E. Smith, ... retained to lead a national chief nursing officer recruitment for Jane ... in the healthcare industry, B. E. Smith has recently placed more than 1,000 ...
(Date:7/3/2015)... CT (PRWEB) , ... July 03, 2015 , ... Smoothies ... home is a good blender and easily accessible, quality ingredients. Aurora Natural is proud ... smoothie for an added boost of fiber, protein, antioxidants, vitamins and minerals! , Aurora ...
(Date:7/3/2015)... ... July 03, 2015 , ... Jennifer Renee Hanes, DO is the new ... the largest network of independent freestanding emergency rooms in the United States. , “We ... Sienna Plantation facility,” said Executive Medical Director of First Choice Emergency Room, Dr. James ...
(Date:7/3/2015)... ... July 03, 2015 , ... " Selfie on a Stick ... the latest and coolest technology products available to consumers. Amanda Forstrom, a technology expert ... selfie sticks are great for documenting memories. , Almost every smartphone has an incredibly ...
Breaking Medicine News(10 mins):Health News:Dr. Rod J. Rohrich Announces the Dates for 2016 Dallas Rhinoplasty Symposium 2Health News:Dr. Rod J. Rohrich Announces the Dates for 2016 Dallas Rhinoplasty Symposium 3Health News:Jane Phillips Medical Center Retains B. E. Smith to Recruit New Chief Nursing Officer 2Health News:Jane Phillips Medical Center Retains B. E. Smith to Recruit New Chief Nursing Officer 3Health News:Aurora Product, Inc. Announces An Original New Line: Smoothie Fixins’ 2Health News:Dr. Jennifer Renee Hanes Named by First Choice Emergency Room as Medical Director of Missouri City, TX Facility 2Health News:Dr. Jennifer Renee Hanes Named by First Choice Emergency Room as Medical Director of Missouri City, TX Facility 3Health News:Learn How to Take Selfies like Kendall Jenner 2
... ... improved longevity , ... YORK (PRWEB) March 30, 2010 -- CogniFit™, Inc., a leading maker of Brain Fitness ... longevity, author and speaker, is now an official spokesperson for CogniFit. Berg, who is ...
... ... , ... (PRWEB) March 30, 2010 -- Canadian Web Hosting ( http://www.canadianwebhosting.com ), a leading provider ... for their popular affiliate program. The immediate increase from $35 to $60 for sales ...
... Medicine found that women with serum uric acid levels over ... than men. This study, the first to examine the ... also evaluated purported risk factors for gout and found that ... be among leading contributors for women. Results of this ...
... others much less severe is largely a mystery. It ... be attributed to differences in how individuals respond to ... for General Microbiology,s spring meeting in Edinburgh today, describes ... allow treatments to be tailored to individuals. This approach ...
... patients are also at high risk for coverage gap, ... Among elderly Americans, women and those with diabetes and ... Medicare Part D drug plan "doughnut hole," the coverage ... annual coverage limit but hasn,t spent enough on drugs ...
... very low levels of violence between their parents, they ... new research suggests. A study by psychologists at ... witness violence between their mother and her intimate partner ... violence as threatening. The research highlights the importance ...
Cached Medicine News:Health News:CogniFit and Longevity Expert Cooperate to Raise Awareness for the Benefits of Brain Fitness 2Health News:CogniFit and Longevity Expert Cooperate to Raise Awareness for the Benefits of Brain Fitness 3Health News:Canadian Web Hosting Increases Affiliate Incentive 2Health News:Obesity, hypertension, alcohol and diuretic use -- gout risk factors for women 2Health News:Personalizing medicine to prevent pandemics 2Health News:Women, Diabetics Fall Fast Into Medicare 'Doughnut Hole' 2Health News:Children's sense of threat from parental fighting determines trauma symptoms 2
... cholangiography and bile stone ... lumen catheter design allows ... and wire basket placement ... sterile in peel-open packages. ...
... biopsy with the MAMMOTOME® HH ... minimally invasive procedure using ultrasound ... computer-generated images to locate breast ... pinpoint and map the area ...
... a more occlusive wrap than VICRYL knitted ... transudate must be contained. Predictable absorption. Polyglactin ... nonantigenic, and nonpyrogenic. ,VICRYL (polyglactin 910) woven ... copolymer of glycolide and lactide, derived respectively ...
Used for implantation to reinforce soft tissue. Supplied sterile in peel-open packages. Intended for one-time use....
Medicine Products: